{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:12:42Z","timestamp":1773681162711,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,30]]},"DOI":"10.7759\/cureus.41165","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T07:18:47Z","timestamp":1688109527000},"source":"Crossref","is-referenced-by-count":7,"title":["A Comprehensive Review of Pregnancy in Sickle Cell Disease"],"prefix":"10.7759","author":[{"given":"Tejas","family":"Shegekar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandhya","family":"Pajai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijns5020020","article-title":"Sickle cell disease-genetics, pathophysiology, clinical presentation and treatment","volume":"5","author":"Inusa BP","year":"2019","unstructured":"Inusa BP, Hsu LL, Kohli N, Patel A, Ominu-Evbota K, Anie KA, Atoyebi W. Sickle cell disease-genetics, pathophysiology, clinical presentation and treatment. Int J Neonatal Screen. 2019, 5:20. 10.3390\/ijns5020020","journal-title":"Int J Neonatal Screen"},{"key":"ref2","article-title":"Sickle cell trait. [Updated 2022 Jul 18]","author":"Ashorobi D","year":"2023","unstructured":"Ashorobi D, Ramsey A, Yarrarapu SNS, et al.. Sickle cell trait. [Updated 2022 Jul 18]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref3","unstructured":"Newborn screening program - sickle cell beta thalassemia disease. Accessed. June 8, 2023: http:\/\/www.idph.state.il.us\/HealthWellness\/fs\/sickle_cell_beta_thalassemia.htm."},{"key":"ref4","unstructured":"What is sickle cell disease?. (2022). Accessed. September 26, 2022: https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/facts.html."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14423\/SMJ.0000000000000514","article-title":"Sickle cell disease in pregnancy","volume":"109","author":"Hathaway AR","year":"2016","unstructured":"Hathaway AR. Sickle cell disease in pregnancy. South Med J. 2016, 109:554-6. 10.14423\/SMJ.0000000000000514","journal-title":"South Med J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0000000000001004","article-title":"Peripartum considerations in sickle cell disease","volume":"34","author":"Ezihe-Ejiofor A","year":"2021","unstructured":"Ezihe-Ejiofor A, Jackson J. Peripartum considerations in sickle cell disease. Curr Opin Anaesthesiol. 2021, 34:212-7. 10.1097\/ACO.0000000000001004","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref7","unstructured":"Data &amp; statistics on sickle cell disease. (2022). Accessed. October 8, 2022: https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/data.html."},{"key":"ref8","unstructured":"Global impact of SCD. Accessed. October 8, 2022: https:\/\/www.notaloneinsicklecell.com\/Global-Impact-Of-SCD\/."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.5.1685","article-title":"Effect of active prenatal management on pregnancy outcome in sickle cell disease in an African setting","volume":"96","author":"Rahimy MC","year":"2000","unstructured":"Rahimy MC, Gangbo A, Adjou R, Deguenon C, Goussanou S, Alihonou E. Effect of active prenatal management on pregnancy outcome in sickle cell disease in an African setting. Blood. 2000, 96:1685-9. 10.1182\/blood.V96.5.1685","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000851688.00394.f4","article-title":"PB2215: Global epidemiology of sickle cell disease: a systematic literature review","volume":"6","author":"Colombatti R","year":"2022","unstructured":"Colombatti R, Birkeg\u00e5rd C, Medici M. PB2215: Global epidemiology of sickle cell disease: a systematic literature review. Hemasphere. 2022, 6:2085-6. 10.1097\/01.HS9.0000851688.00394.f4","journal-title":"Hemasphere"},{"key":"ref11","unstructured":"Office of the registrar general &amp; census commissioner, India. Accessed. October 8, 2022: https:\/\/censusindia.gov.in\/census.website\/."},{"key":"ref12","article-title":"Sickle cell disease in tribal populations in India","volume":"141","author":"Colah RB","year":"2015","unstructured":"Colah RB, Mukherjee MB, Martin S, Ghosh K. Sickle cell disease in tribal populations in India. Indian J Med Res. 2015, 141:509-15.","journal-title":"Indian J Med Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709113371107","article-title":"Pathogenesis and treatment of sickle cell disease","volume":"337","author":"Bunn HF","year":"1997","unstructured":"Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997, 337:762-9. 10.1056\/NEJM199709113371107","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees DC","year":"2010","unstructured":"Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010, 376:2018-31. 10.1016\/S0140-6736(10)61029-X","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)07330-3","article-title":"Sickle-cell disease","volume":"350","author":"Serjeant GR","year":"1997","unstructured":"Serjeant GR. Sickle-cell disease. Lancet. 1997, 350:725-30. 10.1016\/S0140-6736(97)07330-3","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0708445","article-title":"Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy","volume":"85","author":"Lanaro C","year":"2009","unstructured":"Lanaro C, Franco-Penteado CF, Albuqueque DM, Saad ST, Conran N, Costa FF. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy. J Leukoc Biol. 2009, 85:235-42. 10.1189\/jlb.0708445","journal-title":"J Leukoc Biol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2014.09.037","article-title":"Venous thromboembolism in pregnant women with sickle cell disease: a retrospective database analysis","volume":"134","author":"Seaman CD","year":"2014","unstructured":"Seaman CD, Yabes J, Li J, Moore CG, Ragni MV. Venous thromboembolism in pregnant women with sickle cell disease: a retrospective database analysis. Thromb Res. 2014, 134:1249-52. 10.1016\/j.thromres.2014.09.037","journal-title":"Thromb Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.04.016","article-title":"Morbidity associated with sickle cell disease in pregnancy","volume":"199","author":"Villers MS","year":"2008","unstructured":"Villers MS, Jamison MG, De Castro LM, James AH. Morbidity associated with sickle cell disease in pregnancy. Am J Obstet Gynecol. 2008, 199:125.e1-125.e1255. 10.1016\/j.ajog.2008.04.016","journal-title":"Am J Obstet Gynecol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2005.07.003","article-title":"Pregnancy and sickle cell disease","volume":"19","author":"Hassell K","year":"2005","unstructured":"Hassell K. Pregnancy and sickle cell disease. Hematol Oncol Clin North Am. 2005, 19:903-16, vii-viii. 10.1016\/j.hoc.2005.07.003","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2015.11.018","article-title":"Pregnancy and sickle cell disease: a review of the current literature","volume":"98","author":"Boga C","year":"2016","unstructured":"Boga C, Ozdogu H. Pregnancy and sickle cell disease: a review of the current literature. Crit Rev Oncol Hematol. 2016, 98:364-74. 10.1016\/j.critrevonc.2015.11.018","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref21","unstructured":"Sickle cell disease and pregnancy. Accessed. October 10, 2022: https:\/\/www.marchofdimes.org\/complications\/sickle-cell-disease-and-pregnancy.aspx."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13270","article-title":"Pregnancy outcome in patients with sickle cell disease in the UK-a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease","volume":"169","author":"Oteng-Ntim E","year":"2015","unstructured":"Oteng-Ntim E, Ayensah B, Knight M, Howard J. Pregnancy outcome in patients with sickle cell disease in the UK-a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease. Br J Haematol. 2015, 169:129-37. 10.1111\/bjh.13270","journal-title":"Br J Haematol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.13786","article-title":"Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a\u00a0systematic review and meta-analysis","volume":"123","author":"Boafor TK","year":"2016","unstructured":"Boafor TK, Olayemi E, Galadanci N, et al.. Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a\u00a0systematic review and meta-analysis. BJOG. 2016, 123:691-8. 10.1111\/1471-0528.13786","journal-title":"BJOG"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2019000039","article-title":"Complications in pregnant women with sickle cell disease","volume":"2019","author":"Smith-Whitley K","year":"2019","unstructured":"Smith-Whitley K. Complications in pregnant women with sickle cell disease. Hematology Am Soc Hematol Educ Program. 2019, 2019:359-66. 10.1182\/hematology.2019000039","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1963.03710130028008","article-title":"Sickle cell trait and pregnancy","volume":"186","author":"Whalley PJ","year":"1963","unstructured":"Whalley PJ, Pritchard JA, Richards JR Jr.. Sickle cell trait and pregnancy. JAMA. 1963, 186:1132-35. 10.1001\/jama.1963.03710130028008","journal-title":"JAMA"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2019.040","article-title":"Sickle cell disease and pregnancy","volume":"11","author":"Jain D","year":"2019","unstructured":"Jain D, Atmapoojya P, Colah R, Lodha P. Sickle cell disease and pregnancy. Mediterr J Hematol Infect Dis. 2019, 11:e2019040. 10.4084\/MJHID.2019.040","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref27","unstructured":"Evidence-based management of sickle cell disease - expert panel report. (2014). https.\/\/www.nhlbi.nih.gov\/health-topics\/evidence-based-management-sickle-cell-disease."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c5132","article-title":"Effectiveness of earlier antenatal screening for sickle cell disease and thalassaemia in primary care: cluster randomised trial","volume":"341","author":"Dormandy E","year":"2010","unstructured":"Dormandy E, Gulliford M, Bryan S, et al.. Effectiveness of earlier antenatal screening for sickle cell disease and thalassaemia in primary care: cluster randomised trial. BMJ. 2010, 341:c5132. 10.1136\/bmj.c5132","journal-title":"BMJ"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2011.178939","article-title":"Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia","volume":"58","author":"Barrett AN","year":"2012","unstructured":"Barrett AN, McDonnell TCR, Chan KCA, et al.. Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia. Clin Chem. 2012, 58:1026-32. 10.1373\/clinchem.2011.178939","journal-title":"Clin Chem"},{"key":"ref30","article-title":"Invasive & non-invasive approaches for prenatal diagnosis of haemoglobinopathies: experiences from India","volume":"134","author":"Colah RB","year":"2011","unstructured":"Colah RB, Gorakshakar AC, Nadkarni AH. Invasive &amp; non-invasive approaches for prenatal diagnosis of haemoglobinopathies: experiences from India. Indian J Med Res. 2011, 134:552-60.","journal-title":"Indian J Med Res"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1586\/erm.11.7","article-title":"Prenatal, noninvasive and preimplantation genetic diagnosis of inherited disorders: hemoglobinopathies","volume":"11","author":"Traeger-Synodinos J","year":"2011","unstructured":"Traeger-Synodinos J, Vrettou C, Kanavakis E. Prenatal, noninvasive and preimplantation genetic diagnosis of inherited disorders: hemoglobinopathies. Expert Rev Mol Diagn. 2011, 11:299-312. 10.1586\/erm.11.7","journal-title":"Expert Rev Mol Diagn"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2013.03.023","article-title":"Current management of sickle cell disease in pregnancy","volume":"33","author":"Andemariam B","year":"2013","unstructured":"Andemariam B, Browning SL. Current management of sickle cell disease in pregnancy. Clin Lab Med. 2013, 33:293-310. 10.1016\/j.cll.2013.03.023","journal-title":"Clin Lab Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17671","article-title":"Management of sickle cell disease in pregnancy. A British Society for Haematology guideline","volume":"194","author":"Oteng-Ntim E","year":"2021","unstructured":"Oteng-Ntim E, Pavord S, Howard R, et al.. Management of sickle cell disease in pregnancy. A British Society for Haematology guideline. Br J Haematol. 2021, 194:980-95. 10.1111\/bjh.17671","journal-title":"Br J Haematol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjhh.2014.05.007","article-title":"Clinical complications in pregnant women with sickle cell disease: prospective study of factors predicting maternal death or near miss","volume":"36","author":"Resende Cardoso PS","year":"2014","unstructured":"Resende Cardoso PS, Lopes Pessoa de Aguiar RA, Viana MB. Clinical complications in pregnant women with sickle cell disease: prospective study of factors predicting maternal death or near miss. Rev Bras Hematol Hemoter. 2014, 36:256-63. 10.1016\/j.bjhh.2014.05.007","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2013-101392","article-title":"Would you terminate a pregnancy affected by sickle cell disease? Analysis of views of patients in Cameroon","volume":"40","author":"Wonkam A","year":"2014","unstructured":"Wonkam A, de Vries J, Royal CD, Ramesar R, Angwafo FF 3rd. Would you terminate a pregnancy affected by sickle cell disease? Analysis of views of patients in Cameroon. J Med Ethics. 2014, 40:615-20. 10.1136\/medethics-2013-101392","journal-title":"J Med Ethics"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/0268-960x(95)90021-7","article-title":"Sickle cell disease and pregnancy","volume":"9","author":"Koshy M","year":"1995","unstructured":"Koshy M. Sickle cell disease and pregnancy. Blood Rev. 1995, 9:157-64. 10.1016\/0268-960x(95)90021-7","journal-title":"Blood Rev"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2020.1786054","article-title":"Management of sickle cell disease during pregnancy: experience in a third-level hospital and future recommendations","volume":"35","author":"Montironi R","year":"2022","unstructured":"Montironi R, Cupaiolo R, Kadji C, et al.. Management of sickle cell disease during pregnancy: experience in a third-level hospital and future recommendations. J Matern Fetal Neonatal Med. 2022, 35:2345-54. 10.1080\/14767058.2020.1786054","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830420311","article-title":"Doppler velocimetry in pregnant patients with sickle cell anemia","volume":"42","author":"Billett HH","year":"1993","unstructured":"Billett HH, Langer O, Regan OT, Merkatz I, Anyaegbunam A. Doppler velocimetry in pregnant patients with sickle cell anemia. Am J Hematol. 1993, 42:305-8. 10.1002\/ajh.2830420311","journal-title":"Am J Hematol"},{"key":"ref39","article-title":"Third-trimester prediction of small-for-gestational-age infants in pregnant women with sickle cell disease. Development of the ultradop index","volume":"36","author":"Anyaegbunam A","year":"1991","unstructured":"Anyaegbunam A, Langer O, Brustman L, Whitty J, Merkatz IR. Third-trimester prediction of small-for-gestational-age infants in pregnant women with sickle cell disease. Development of the ultradop index. J Reprod Med. 1991, 36:577-80.","journal-title":"J Reprod Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/jca.2920060412","article-title":"Management of sickle cell anemia and pregnancy","volume":"6","author":"Koshy M","year":"1991","unstructured":"Koshy M, Chisum D, Burd L, Orlina A, How H. Management of sickle cell anemia and pregnancy. J Clin Apher. 1991, 6:230-3. 10.1002\/jca.2920060412","journal-title":"J Clin Apher"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1097\/00003081-199509000-00007","article-title":"Pregnancy complicated by sickle hemoglobinopathy","volume":"38","author":"Rust OA","year":"1995","unstructured":"Rust OA, Perry KG Jr. Pregnancy complicated by sickle hemoglobinopathy. Clin Obstet Gynecol. 1995, 38:472-84. 10.1097\/00003081-199509000-00007","journal-title":"Clin Obstet Gynecol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-199711000-00021","article-title":"Management of nonobstetric pain during pregnancy and lactation","volume":"85","author":"Rathmell JP","year":"1997","unstructured":"Rathmell JP, Viscomi CM, Ashburn MA. Management of nonobstetric pain during pregnancy and lactation. Anesth Analg. 1997, 85:1074-87. 10.1097\/00000539-199711000-00021","journal-title":"Anesth Analg"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198805000-00023","article-title":"Epidural analgesia in the management of labor pain and sickle cell crisis\u2014a case report","volume":"68","author":"Finer P","year":"1988","unstructured":"Finer P, Blair J, Rowe P. Epidural analgesia in the management of labor pain and sickle cell crisis\u2014a case report. Anesthesiology. 1988, 68:799-800. 10.1097\/00000542-198805000-00023","journal-title":"Anesthesiology"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1361931","article-title":"Impact of sickle hemoglobinopathies on pregnancy-related venous thromboembolism","volume":"31","author":"Porter B","year":"2014","unstructured":"Porter B, Key NS, Jauk VC, Adam S, Biggio J, Tita A. Impact of sickle hemoglobinopathies on pregnancy-related venous thromboembolism. Am J Perinatol. 2014, 31:805-9. 10.1055\/s-0033-1361931","journal-title":"Am J Perinatol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2010.02.015","article-title":"Sickle cell disease in pregnancy","volume":"37","author":"Rogers DT","year":"2010","unstructured":"Rogers DT, Molokie R. Sickle cell disease in pregnancy. Obstet Gynecol Clin North Am. 2010, 37:223-37. 10.1016\/j.ogc.2010.02.015","journal-title":"Obstet Gynecol Clin North Am"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19871101)60:9<2177::aid-cncr2820600911>3.0.co;2-p","article-title":"Excretion of hydroxyurea into milk","volume":"60","author":"Sylvester RK","year":"1987","unstructured":"Sylvester RK, Lobell M, Teresi ME, Brundage D, Dubowy R. Excretion of hydroxyurea into milk. Cancer. 1987, 60:9-2177. 10.1002\/1097-0142(19871101)60:9&lt;2177::aid-cncr2820600911&gt;3.0.co;2-p","journal-title":"Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/122139-a-comprehensive-review-of-pregnancy-in-sickle-cell-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:00:33Z","timestamp":1707508833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/122139-a-comprehensive-review-of-pregnancy-in-sickle-cell-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,30]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.41165","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,30]]}}}